Preoperative chemotherapy in non-small-cell lung cancer: Nothing new in N2 disease

被引:1
|
作者
De Pas, T [1 ]
Pastorino, U
Spaggiari, L
Curigliano, G
de Braud, F
Robertson, C
机构
[1] European Inst Oncol, Milan, Italy
[2] Univ Strathclyde, Glasgow, Lanark, Scotland
[3] Scottish Ctr Infect & Environm Hlth, Glasgow, Lanark, Scotland
关键词
D O I
10.1200/JCO.2002.20.10.2603
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2603 / 2604
页数:2
相关论文
共 50 条
  • [31] Postoperative Radiotherapy for Pathologic N2 Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: Need for Randomized Evidence
    Le Pechoux, Cecile
    Dunant, Ariane
    Faivre-Finn, Corinne
    Thomas, Pascal-Alexandre
    Pourel, Nicolas
    Lerouge, Delphine
    Edwards, John
    Van Schil, Paul
    Rami-Porta, Ramon
    Dansin, Eric
    Nestle, Ursula
    Fadel, Elie
    Zalcman, Gerard
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (26) : 2930 - +
  • [32] Adjuvant chemotherapy of non-small-cell lung cancer
    Rixe, O
    LeChevalier, T
    ADJUVANT THERAPY OF CANCER VIII, 1997, 8 : 71 - 73
  • [33] A new approach to predicting risk for N2 disease in non-small cell lung cancer
    Decker, Roy H.
    Blasberg, Justin D.
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S1973 - S1975
  • [34] Maintenance chemotherapy for non-small-cell lung cancer
    Kim, Young Hak
    Mishima, Michiaki
    CANCER TREATMENT REVIEWS, 2011, 37 (07) : 505 - 510
  • [35] CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER
    THATCHER, N
    RANSON, M
    LEE, SM
    NIVEN, R
    ANDERSON, H
    ANNALS OF ONCOLOGY, 1995, 6 : 83 - 95
  • [36] Pharmacogenomics in non-small-cell lung cancer chemotherapy
    Danesi, Romano
    Pasqualetti, Giuseppe
    Giovannetti, Elisa
    Crea, Francesco
    Altavilla, Giuseppe
    Del Tacca, Mario
    Rosell, Rafael
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (05) : 408 - 417
  • [37] CHEMOTHERAPY OF NON-SMALL-CELL LUNG-CANCER
    KLASTERSKY, J
    SCULIER, JP
    SEMINARS IN ONCOLOGY, 1985, 12 (04) : 38 - 48
  • [38] Adjuvant chemotherapy plus radiotherapy is superior to chemotherapy following surgical treatment of stage IIIA N2 non-small-cell lung cancer
    Lei, Tao
    Xu, Xiao-Ling
    Chen, Wei
    Xu, Ya-Ping
    Mao, Wei-Min
    ONCOTARGETS AND THERAPY, 2016, 9 : 921 - 928
  • [39] Trends and Outcomes in Minimally Invasive Surgery for Locally Advanced Non-Small-Cell Lung Cancer With N2 Disease
    Herb, Joshua N.
    Kindell, Daniel G.
    Strassle, Paula D.
    Stitzenberg, Karyn B.
    Haithcock, Benjamin E.
    Mody, Gita N.
    Long, Jason M.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2021, 33 (02) : 547 - 555
  • [40] Multimodality Treatment With Surgery for Locally Advanced Non-Small-Cell Lung Cancer With N2 Disease: A Review Article
    Toyokawa, Gouji
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    CLINICAL LUNG CANCER, 2015, 16 (01) : 6 - 14